Search Results - "Accardi, Fabrizio"

Refine Results
  1. 1

    Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myeloma by Bae, Jooeun, Accardi, Fabrizio, Hideshima, Teru, Tai, Yu-Tzu, Prabhala, Rao, Shambley, Aaron, Wen, Kenneth, Rowell, Sean, Richardson, Paul G., Munshi, Nikhil C., Anderson, Kenneth C.

    Published in Leukemia (01-01-2022)
    “…Immune profiling in patients with monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma (SMM), and multiple myeloma (MM)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling by Aversa, Franco, Dalla Palma, Benedetta, Bolzoni, Marina, Toscani, Denise, Accardi, Fabrizio, Giuliani, Nicola

    Published in BioMed research international (01-01-2015)
    “…Multiple myeloma (MM) is characterized by a high capacity to induce alterations in the bone remodeling process. The increase in osteoclastogenesis and the…”
    Get full text
    Journal Article
  4. 4

    The Proteasome and Myeloma-Associated Bone Disease by Accardi, Fabrizio, Toscani, Denise, Costa, Federica, Aversa, Franco, Giuliani, Nicola

    Published in Calcified tissue international (01-02-2018)
    “…Bone disease is the hallmark of multiple myeloma (MM), a hematological malignancy characterized by osteolytic lesions due to a severe uncoupled and unbalanced…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    The osteoblastic niche in the context of multiple myeloma by Toscani, Denise, Bolzoni, Marina, Accardi, Fabrizio, Aversa, Franco, Giuliani, Nicola

    Published in Annals of the New York Academy of Sciences (01-01-2015)
    “…The osteoblastic niche has a critical role in the regulation of hemopoietic stem cell (HSC) quiescence and self‐renewal and in the support of hematopoiesis…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Novel targets for the treatment of relapsing multiple myeloma by Giuliani, Nicola, Accardi, Fabrizio, Marchica, Valentina, Dalla Palma, Benedetta, Storti, Paola, Toscani, Denise, Vicario, Emanuela, Malavasi, Fabio

    Published in Expert review of hematology (03-07-2019)
    “…: Multiple myeloma (MM) is characterized by the high tendency to relapse and develop drug resistance. : This review focused on the main novel targets…”
    Get more information
    Journal Article
  19. 19

    Short-Term Risk of Progression of Patients with Asymptomatic Monoclonal Gammopathies to Active Multiple Myeloma: The Critical Impact of the Tumoral Mass by Dalla Palma, Anna Benedetta, Notarfranchi, Laura, Crosara, Jessica, Pedrazzoni, Mario, Accardi, Fabrizio, Marchica, Valentina, Toscani, Denise, Vicario, Emanuela, Storti, Paola, Giuliani, Nicola

    Published in Blood (13-11-2019)
    “…The identification of risk factors for progression is critical in the clinical management and appropriate follow up of patients with pre-malignant Asymptomatic…”
    Get full text
    Journal Article
  20. 20